Englander Institute for Precision Medicine

Publications

Found 692 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bellmunt J, de Wit R, Fradet Y, Climent MA, Petrylak DP, Lee J-L, Fong L, Necchi A, Sternberg CN, O'Donnell PH et al..  2022.  Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.. Clin Cancer Res. 28(10):2050-2060.
Beltran H, Prandi D, Mosquera JMiguel, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BVSK, Varambally S et al..  2016.  Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.. Nat Med. 22(3):298-305.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Romanel A, Conteduca V, Casiraghi N, Sigouros M, Franceschini GMarco, Orlando F, Fedrizzi T, Ku S-Y, Dann E et al..  2020.  Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.. J Clin Invest. 130(4):1653-1668.
Beltrán-Visiedo M, Balachandran S, Galluzzi L.  2024.  MRE11 mobilizes CGAS and drives ZBP1-dependent necroptosis.. Cell Res.
Benedetti E, Gerstner N, Pučić-Baković M, Keser T, Reiding KR, L Ruhaak R, Štambuk T, Selman MHJ, Rudan I, Polašek O et al..  2020.  Systematic Evaluation of Normalization Methods for Glycomics Data Based on Performance of Network Inference.. Metabolites. 10(7)
Benedetti E, Pučić-Baković M, Keser T, Gerstner N, Buyukozkan M, Štambuk T, Selman MHJ, Rudan I, Polašek O, Hayward C et al..  2020.  A strategy to incorporate prior knowledge into correlation network cutoff selection.. Nat Commun. 11(1):5153.
Benedetti E, Chetnik K, Flynn T, Barbieri CE, Scherr DS, Loda M, Krumsiek J.  2023.  Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohort.. Sci Data. 10(1):830.
Benedetti E, Liu EMinwei, Tang C, Kuo F, Buyukozkan M, Park T, Park J, Correa F, A Hakimi A, Intlekofer AM et al..  2023.  A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation.. Nat Metab. 5(6):1029-1044.
Benelli M, Romagnoli D, Demichelis F.  2018.  Tumor purity quantification by clonal DNA methylation signatures.. Bioinformatics. 34(10):1642-1649.
Bensoussan Y, Elemento O, Rameau A.  2024.  Voice as an AI Biomarker of Health-Introducing Audiomics.. JAMA Otolaryngol Head Neck Surg.
Berchuck JE, Baca SC, McClure HM, Korthauer K, Tsai HK, Nuzzo PVitale, Kelleher KM, He M, Steinharter JA, Zacharia S et al..  2022.  Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.. Clin Cancer Res. 28(5):928-938.
Berger A, Brady NJ, Bareja R, Robinson B, Conteduca V, Augello MA, Puca L, Ahmed A, Dardenne E, Lu X et al..  2019.  N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.. J Clin Invest. 129(9):3924-3940.
Beyer J, Collette L, Sauvé N, Daugaard G, Feldman DR, Tandstad T, Tryakin A, Stahl O, Gonzalez-Billalabeitia E, De Giorgi U et al..  2021.  Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.. J Clin Oncol. 39(14):1553-1562.
Bhardwaj P, Ikeda T, Zhou XKathy, Wang H, Zheng XEmily, Giri DD, Elemento O, Verma A, Miyazawa M, Mukherjee S et al..  2019.  Supplemental estrogen and caloric restriction reduce obesity-induced periprostatic white adipose inflammation in mice.. Carcinogenesis. 40(7):914-923.
Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJun, Choi MHo, Sun Q, Savenkov O, Louka C, Liu C et al..  2023.  Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in .. Sci Transl Med. 15(684):eade1857.
Bhinder B, Gilvary C, Madhukar NS, Elemento O.  2021.  Artificial Intelligence in Cancer Research and Precision Medicine.. Cancer Discov. 11(4):900-915.
Bhinder B, Elemento O.  2020.  Computational methods in tumor immunology.. Methods Enzymol. 636:209-259.
Björndahl L, Barratt CLR, Mortimer D, Agarwal A, Aitken RJ, Alvarez JG, Aneck-Hahn N, Arver S, Baldi E, Bassas L et al..  2022.  Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology.. Hum Reprod. 37(11):2497-2502.
Blattner M, Liu D, Robinson BD, Huang D, Poliakov A, Gao D, Nataraj S, Deonarine LD, Augello MA, Sailer V et al..  2017.  SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.. Cancer Cell. 31(3):436-451.
Bloehdorn J, Braun A, Taylor-Weiner A, Jebaraj BMichael Ch, Robrecht S, Krzykalla J, Pan H, Giza A, Akylzhanova G, Holzmann K et al..  2021.  Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia.. Nat Commun. 12(1):5395.
Boeck N, Trajanoski Z, Galluzzi L.  2023.  Bacterial antigens unleash tumor-targeting immunity.. Cell Host Microbe. 31(12):1945-1947.
Boehm KMichael, Bhinder B, Raja VJoseph, Dephoure N, Elemento O.  2019.  Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.. BMC Bioinformatics. 20(1):7.
Borregales LD, Venkat S, Calderon LPosada, Lewicki P, Flynn T, Faltas BM, Molina AM, Golombos DM, O'Malley P, Scherr DS.  2023.  A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder Cancer.. Eur Urol. 84(6):604-606.
Bourdenx M, Martín-Segura A, Scrivo A, Rodriguez-Navarro JA, Kaushik S, Tasset I, Diaz A, Storm NJ, Xin Q, Juste YR et al..  2021.  Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome.. Cell. 184(10):2696-2714.e25.